Clinical Trial Site

Garran 2605

0 studies enrolling now · 2 studies all time

What they study most

High Cardiovascular Risk, Hypertension, Primary Hyperoxaluria, Primary Hyperoxaluria Type 1

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 — Completed